• Ibotenic Acid (SKU B6246): Robust Models for Neurotoxicity R

  2026-06-03

  This article explores real-world laboratory scenarios where Ibotenic acid (SKU B6246) addresses pain points in neurodegenerative disease modeling, assay reproducibility, and workflow optimization. Backed by recent in vivo data and practical protocol guidance, it demonstrates how researchers can achieve reliable, reproducible results using this high-purity NMDA receptor agonist.

• ZK53: Advancing Selective Human ClpP Activation in Oncology

  2026-06-03

  This thought-leadership article explores how ZK53, a highly selective human mitochondrial serine protease ClpP activator, is transforming translational research in cancer biology. We highlight mechanistic insights, protocol recommendations, and strategic guidance for researchers, supported by recent peer-reviewed evidence and real-world workflow applications.

• Topological Stress Drives Persistent rDNA Damage and PML-Nuc

  2026-06-02

  This study uncovers how topological stress and RNA polymerase I inhibition precipitate persistent DNA lesions within ribosomal DNA, driving the formation of PML-nucleolar associations (PNAs). The findings illuminate the interplay between rDNA damage, DNA repair pathways, and nuclear organization, providing new mechanistic insight into genome stability and cellular fate.

• Neuromedin S (rat): Technical Use, Protocols, and QC Guidanc

  2026-06-02

  Neuromedin S (rat) is a chemically defined peptide agonist supporting precise activation of neuromedin U receptor signaling in rat-based GPCR/G protein research. It is intended strictly for controlled laboratory assays focusing on physiological signaling pathways such as energy homeostasis and stress response, and should not be used for diagnostic or therapeutic purposes.

• Deferiprone: Iron Chelator for Cancer and Metabolic Research

  2026-06-01

  Deferiprone is a selective iron-chelating agent widely used to investigate iron-mediated cellular processes, including apoptosis induction and oxidative stress modulation. It forms stable tris-complexes with ferric ions and demonstrates potent effects in cancer biology and neurovascular research. APExBIO's Deferiprone (B1723) enables precise control of cellular iron and supports advanced metabolic assays.

• TaqI Restriction Endonuclease: Rapid, Sequence-Specific DNA

  2026-06-01

  TaqI Restriction Endonuclease enables fast and efficient DNA cleavage for plasmid, PCR, and genomic DNA workflows, reducing digestion time to minutes. It is designed for research applications requiring sticky-end generation but is not intended for diagnostic or clinical use.

• Benzo[a]pyrene Drives Immunosuppression in Prostate Cancer P

  2026-05-31

  This study reveals that benzo[a]pyrene (BaP), a major polycyclic aromatic hydrocarbon, enhances prostate cancer growth and impairs immune cell infiltration in both in vitro and in vivo models. The findings highlight the environmental impact of BaP on tumor biology and the immune microenvironment, providing key mechanistic insights for cancer research.

• Lung-Targeted Risedronate Sodium Dendrimers Advance Osteopor

  2026-05-30

  This study introduces a lung-targeted dendrimer-based delivery system for Risedronate Sodium and vitamin D₃, offering improved bioavailability and reduced gastrointestinal side effects in osteoporosis models. The findings support a paradigm shift toward inhaled bisphosphonate therapies with molecular evidence of restored bone density and metabolic normalization.

• Antimycin A4: Protocols for Dual ATP-Citrate Lyase Inhibitio

  2026-05-29

  Antimycin A4 stands out as a precision ATP-citrate lyase inhibitor and mitochondrial respiratory chain blocker, enabling advanced dissection of cellular energy metabolism. This guide provides actionable workflows, troubleshooting strategies, and experimental insights to maximize research reproducibility and interpretability when using this dual-action compound.

• Methotrexate as a Folate Antagonist: Translational Power & F

  2026-05-29

  This thought-leadership article explores the mechanistic underpinnings and strategic opportunities of methotrexate as a folate antagonist, focusing on its unique dual roles in apoptosis research and immunosuppression. Bridging robust experimental protocols with translational insight, it guides researchers through emerging applications, evidence-driven workflows, and the evolving landscape of anti-inflammatory and neurological research.

• Adefovir (GS-0393): Optimizing HBV Antiviral Workflows

  2026-05-28

  Adefovir (GS-0393) empowers hepatitis B virus research with robust, selective inhibition of HBV DNA polymerase. This article delivers actionable protocols, advanced troubleshooting, and comparative insights that help researchers achieve reproducible, high-fidelity results in both antiviral and renal transporter assay contexts.

• Tacrine Hydrochloride Hydrate: Scaffold Innovation in Alzhei

  2026-05-28

  Explore how Tacrine hydrochloride hydrate serves as a versatile molecular scaffold driving multi-target drug discovery in Alzheimer's disease research. This in-depth article reveals mechanistic insights, advanced applications, and practical assay guidance beyond traditional cholinesterase inhibition.

• Cy3 NHS ester (non-sulfonated): Technical Guide for Protein

  2026-05-27

  Cy3 NHS ester (non-sulfonated) is a specialized fluorescent dye designed for covalent labeling of primary amines on proteins, peptides, and oligonucleotides. It solves solubility and detection challenges in workflows requiring orange fluorescence and compatibility with standard TRITC filter sets, but is not suitable for applications involving water-only labeling buffers or long-term dye storage in solution.

• Parathyroid hormone (1-34) (human) in Advanced Bone and Kidn

  2026-05-27

  Parathyroid hormone (1-34) (human) empowers researchers to model calcium homeostasis and bone metabolism with unrivaled quantitative control, bridging bench workflows from osteoporosis to next-generation kidney assembloids. Leveraging its high bioactivity and solubility, APExBIO’s reagent is the trusted backbone for reproducible, high-fidelity experimental systems.

• Risedronate Sodium in Precision Delivery: Mechanisms and Pro

  2026-05-26

  Explore the advanced mechanisms of Risedronate Sodium as an FPP synthase inhibitor and its impact on bone metabolism research. This article uniquely examines inhaled nanoformulations and practical assay guidance, setting it apart in osteoporosis and emphysema research.

16608 records 1/1108 page Next 12345 下5页 Last page